nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2013-17-3-80-87nefr-501Research ArticleНАБЛЮДЕНИЯ ИЗ ПРАКТИКИPRACTICAL NOTESКАТАМНЕСТИЧЕСКОЕ НАБЛЮДЕНИЕ ДЕТЕЙ С СИНДРОМОМ BARTTER И GITELMANFOLLOW UP MONITORING OF CHILDREN WITH BARTTER AND GITELMAN SYNDROMEЛевиашвилиЖ. Г.LeviashviliJ. G.

Кафедра факультетской педиатрии 

194100, Санкт-Петербург, ул. Литовская, д. 2. Тел. 952-98-09

jannalevi@gmail.comСавенковаН. Д.SavenkovaN. D.

Кафедра факультетской педиатрии

ЛевичеваО. В.LevishevаO. V.

Кафедра факультетской педиатрии

СнежковаЕ. А.SnezhkovaE. A.

Кафедра факультетской педиатрии

Санкт-Петербургский государственный педиатрический медицинский университетRussian Federation2013100320131738087Copyright © Левиашвили Ж.Г., Савенкова Н.Д., Левичева О.В., Снежкова Е.А., 20132013Левиашвили Ж.Г., Савенкова Н.Д., Левичева О.В., Снежкова Е.А.Leviashvili J.G., Savenkova N.D., Levishevа O.V., Snezhkova E.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/501

В статье представлено катамнестические наблюдения детей с Bartter синдром и Gitelman синдром – тубулопатиями с аутосомно-рецессивным типом наследования, проявляющимися гипокалиемией, метаболическим алкалозом, судорогами, задержкой роста, гипомагниемией при Gitelman синдроме. Описаны особенности течения первичного и вторичного Bartter синдрома, также Gitelman синдрома.

The article presents a follow-up monitoring of children with Bartter syndrome and Gitelman syndrome - tubulopathies with autosomal – recessive fashion which manifest by hypokalemia, metabolic alkalosis, convultions, growth restriction, hypomagnesemia in Gitelman syndrome. The features of the course of primary and secondary Bartter syndrome, as well Gitelman syndrome, are descibed.

Bartter синдромGitelman синдромтубулопатиядетикатамнезBartter syndromeGitelman syndrometubulopathychildrenfollow upReferencesEmmett M, Sterns RH, Forman JP. Bartter and Gitelman syndromes. Last literature review version 19.2. 2011; updatedEmmett M, Sterns RH, Forman JP. Bartter and Gitelman syndromes. Last literature review version 19.2. 2011; updatedLifton RP, Somlo S, Giebisch GH, Seldin DW. Genetic disease of the kidney 2009; ELSEVIER 229-247Lifton RP, Somlo S, Giebisch GH, Seldin DW. Genetic disease of the kidney 2009; ELSEVIER 229-247Seyberth HW. An improved terminology and classification of Bartter-like syndromes. Nat Clin Pract Nephrol 2008 [Medline]Seyberth HW. An improved terminology and classification of Bartter-like syndromes. Nat Clin Pract Nephrol 2008 [Medline]Seyberth HW, Schlingmann KP, Bartter – and Gitelman – lake syndromes: salt – losing tubulopathies with loop or DCT defects. Pediatr Nephrol 2011; 26:1789-1802Seyberth HW, Schlingmann KP, Bartter – and Gitelman – lake syndromes: salt – losing tubulopathies with loop or DCT defects. Pediatr Nephrol 2011; 26:1789-1802Sardani Y, Qin K, Haas M. et all. Bartter Syndrome complicadet by immune complex nephropaty. Pediatr Nephrol 2003; 18: 913-918Sardani Y, Qin K, Haas M. et all. Bartter Syndrome complicadet by immune complex nephropaty. Pediatr Nephrol 2003; 18: 913-918Prasad Devarajan, Craig B Langman, Pediatric Bartter Syndrome Updated: (2011), 14Prasad Devarajan, Craig B Langman, Pediatric Bartter Syndrome Updated: (2011), 14Савенкова НД, Папаян АВ, Левиашвили ЖГ. Тубулопатии в практике педиатра. СПб., 2006; 103:114Савенкова НД, Папаян АВ, Левиашвили ЖГ. Тубулопатии в практике педиатра. СПб., 2006; 103:114Левиашвили ЖГ, Савенкова НД. Барттер синдром у детей. Нефрология 2012, 16; 3 (выпуск 2): 25-33Левиашвили ЖГ, Савенкова НД. Барттер синдром у детей. Нефрология 2012, 16; 3 (выпуск 2): 25-33Proesmans W. Treadingthroudh the mizmaze of Bartter syndrome. Pediatr Nephrol 2006; 21:896-902Proesmans W. Treadingthroudh the mizmaze of Bartter syndrome. Pediatr Nephrol 2006; 21:896-902Tourne G, Collet F, Varlet MN, et al. Prenatal Bartter’s syndrome. Report of two cases. J Gynecol Obstet Biol Reprod (Paris) 2003; 32:751Tourne G, Collet F, Varlet MN, et al. Prenatal Bartter’s syndrome. Report of two cases. J Gynecol Obstet Biol Reprod (Paris) 2003; 32:751Bhamkar RP, Gajendragadkar A. Antenatal Bartter’s syndrome with sensorineural deafness. Indian J of Nephrology 2009; 19 (1): 23–26Bhamkar RP, Gajendragadkar A. Antenatal Bartter’s syndrome with sensorineural deafness. Indian J of Nephrology 2009; 19 (1): 23–26Lüthy C, Bettinelli A, Iselin S, et al. Normal prostaglandinuria E2 in Gitelman’s syndrome, the hypocalciuric variant of Bartter’s syndrome. Am J Kidney Dis 1995; 25:824–828Lüthy C, Bettinelli A, Iselin S, et al. Normal prostaglandinuria E2 in Gitelman’s syndrome, the hypocalciuric variant of Bartter’s syndrome. Am J Kidney Dis 1995; 25:824–828Penessi M, Marchetti F, Crovella C, et al. A new mutation in two siblings with cystinosis presenting with Bartter Syndrome. Pediatr Nephrol 2005; 217-219Penessi M, Marchetti F, Crovella C, et al. A new mutation in two siblings with cystinosis presenting with Bartter Syndrome. Pediatr Nephrol 2005; 217-219Vasbich MH, Fujimura MD, Koch VH. Bartter Syndrome: benefits and side effect of long-term treatment. Pediatr Nephrol 2004; 19:858-863Vasbich MH, Fujimura MD, Koch VH. Bartter Syndrome: benefits and side effect of long-term treatment. Pediatr Nephrol 2004; 19:858-863Malafronte C, Borsa N, Tedechi S et al. Cardiac arrythmias due to severe hypocalemia in a patient with classic Bartter Disease. Pediatr Nephrol 2004; 19: 1413-1415Malafronte C, Borsa N, Tedechi S et al. Cardiac arrythmias due to severe hypocalemia in a patient with classic Bartter Disease. Pediatr Nephrol 2004; 19: 1413-1415Birkenhäger R, Otto E, Schürmann MJ, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 2001; 29:31Birkenhäger R, Otto E, Schürmann MJ, et al. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 2001; 29:31Bettinelli A, Borsa N, Bellantuono R, et al. Patients with biallelic mutations in the chloride channel gene CLCNKB: longterm management and outcome. Am J Kidney Dis 2007; 49:91Bettinelli A, Borsa N, Bellantuono R, et al. Patients with biallelic mutations in the chloride channel gene CLCNKB: longterm management and outcome. Am J Kidney Dis 2007; 49:91Kömhoff M, Reinalter SC, Gröne HJ, Seyberth HW. Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies. Pediatr Res 2004; 55:261Kömhoff M, Reinalter SC, Gröne HJ, Seyberth HW. Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies. Pediatr Res 2004; 55:261Morales JM, Ruilope LM, Praga M, et al. Long-term enalapril therapy in Bartter’s syndrome. Nephron 1988; 48:327Morales JM, Ruilope LM, Praga M, et al. Long-term enalapril therapy in Bartter’s syndrome. Nephron 1988; 48:327Kobayashi K, Uchida S, Okamura HO, et al. Human CLCKB gene promoter drives the EGFP expression in the specific distal nephron segments and inner ear. J Am Soc Nephrol (2002); 13:1992Kobayashi K, Uchida S, Okamura HO, et al. Human CLCKB gene promoter drives the EGFP expression in the specific distal nephron segments and inner ear. J Am Soc Nephrol (2002); 13:1992Janssen AG, Scholl U, Domeyer C, et al. Disease-causing dysfunctions of barttin in Bartter syndrome type IV. J Am Soc Nephrol 2009; 20:145 22. Estévez R, Boettger T, Stein V, et al. Barttin is a Cl- channel beta-subunit crucial for renal Cl-reabsorption and inner ear K+ secretion. Nature 2001; 414:558Janssen AG, Scholl U, Domeyer C, et al. Disease-causing dysfunctions of barttin in Bartter syndrome type IV. J Am Soc Nephrol 2009; 20:145 22. Estévez R, Boettger T, Stein V, et al. Barttin is a Cl- channel beta-subunit crucial for renal Cl-reabsorption and inner ear K+ secretion. Nature 2001; 414:558Izzedine H, Tankere F, Launay-Vacher V, Deray G. Ear and kidney syndromes: molecular versus clinical approach. Kidney Int 2004; 65:369Izzedine H, Tankere F, Launay-Vacher V, Deray G. Ear and kidney syndromes: molecular versus clinical approach. Kidney Int 2004; 65:369Konrad M, Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 2003; 14:249Konrad M, Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 2003; 14:249Ji W, Foo JN, O’Roak BJ, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40:592Ji W, Foo JN, O’Roak BJ, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 2008; 40:592Mizuno K, Yamazaki M, Fukuchi S. Hypotensive response to angiotensin I-converting enzyme inhibitor in Bartter’s syndrome. N Engl J Med 1979; 300:1057Mizuno K, Yamazaki M, Fukuchi S. Hypotensive response to angiotensin I-converting enzyme inhibitor in Bartter’s syndrome. N Engl J Med 1979; 300:1057http://www.eurolab.ua/encyclopedia/324/2092/. Феохромоцитома. Эндокринологияhttp://www.eurolab.ua/encyclopedia/324/2092/. Феохромоцитома. ЭндокринологияCalò LA, Marchini F, Davis PA, et al. Kidney transplant in Gitelman’s syndrome. Report of the first case. J Nephrol 2003; 16:144Calò LA, Marchini F, Davis PA, et al. Kidney transplant in Gitelman’s syndrome. Report of the first case. J Nephrol 2003; 16:144Каюков ИГ. Синдромы Барттера и Гительмана у взрослых. Материалы II Всерос. конф. по редким заболеваниям и редко применяемым медицинским технологиям «Дорога жизни» СПб., 21-22 апреля 2011; 34-35.Каюков ИГ. Синдромы Барттера и Гительмана у взрослых. Материалы II Всерос. конф. по редким заболеваниям и редко применяемым медицинским технологиям «Дорога жизни» СПб., 21-22 апреля 2011; 34-35.Madariaga L,Garsia-Castano A, De Nanclares P.G, Long term prognosis of our cjhort of patients with genetically confirmed Bartter syndrome (BS) type II, III. Pediatr Nephrol 2012; 27:1670- 1671Madariaga L,Garsia-Castano A, De Nanclares P.G, Long term prognosis of our cjhort of patients with genetically confirmed Bartter syndrome (BS) type II, III. Pediatr Nephrol 2012; 27:1670- 1671Garsia-Castano A, De Nanclares P.G, Madrid A, Molicular genetic diagnosis of Bartter syndrome (BS) type III. Pediatr Nephrol 2012; 27:1671-1672Garsia-Castano A, De Nanclares P.G, Madrid A, Molicular genetic diagnosis of Bartter syndrome (BS) type III. Pediatr Nephrol 2012; 27:1671-1672Waldegger S, Jentsch TJ. From tonus to tonicity: physiology of CLC chloride channels. J Am Soc Nephrol 2000; 11:1331Waldegger S, Jentsch TJ. From tonus to tonicity: physiology of CLC chloride channels. J Am Soc Nephrol 2000; 11:1331Vigano C, Amoruso C, Barretta F, Renal phosphate handling in Gitelman syndrome the results of case-control. Pediatr Nephrol 2013; 28:65-70Vigano C, Amoruso C, Barretta F, Renal phosphate handling in Gitelman syndrome the results of case-control. Pediatr Nephrol 2013; 28:65-70Hené RJ, Koomans HA, Dorhout Mees EJ, et al. Correction of hypokalemia in Bartter’s syndrome by enalapril. Am J Kidney Dis 1987; 9:200Hené RJ, Koomans HA, Dorhout Mees EJ, et al. Correction of hypokalemia in Bartter’s syndrome by enalapril. Am J Kidney Dis 1987; 9:200Colussi G, Rombolà G, De Ferrari ME, et al. Correction of hypokalemia with antialdosterone therapy in Gitelman’s syndrome. Am J Nephrol 1994; 14:127Colussi G, Rombolà G, De Ferrari ME, et al. Correction of hypokalemia with antialdosterone therapy in Gitelman’s syndrome. Am J Nephrol 1994; 14:127Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol 2007; 18:1271Riveira-Munoz E, Chang Q, Godefroid N, et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol 2007; 18:1271Gross P, Gitelman Syndrome: when will it turn into Gitelman disease. Pediatr Nephrol 2003; 18: 613-616Gross P, Gitelman Syndrome: when will it turn into Gitelman disease. Pediatr Nephrol 2003; 18: 613-616Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001; 37:1458Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001; 37:1458Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. Am J Physiol 1996; 271:C103Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. Am J Physiol 1996; 271:C103Ea HK, Blanchard A, Dougados M, Roux C. Chondrocalcinosis secondary to hypomagnesemia in Gitelman’s syndrome. J Rheumatol 2005; 32:1840Ea HK, Blanchard A, Dougados M, Roux C. Chondrocalcinosis secondary to hypomagnesemia in Gitelman’s syndrome. J Rheumatol 2005; 32:1840

The authors declare that there are no conflicts of interest present.